Correlation Between Pharming Group and Neutra Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharming Group and Neutra Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharming Group and Neutra Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharming Group NV and Neutra Corp, you can compare the effects of market volatilities on Pharming Group and Neutra Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharming Group with a short position of Neutra Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharming Group and Neutra Corp.

Diversification Opportunities for Pharming Group and Neutra Corp

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pharming and Neutra is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and Neutra Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neutra Corp and Pharming Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharming Group NV are associated (or correlated) with Neutra Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neutra Corp has no effect on the direction of Pharming Group i.e., Pharming Group and Neutra Corp go up and down completely randomly.

Pair Corralation between Pharming Group and Neutra Corp

Assuming the 90 days horizon Pharming Group NV is expected to under-perform the Neutra Corp. But the pink sheet apears to be less risky and, when comparing its historical volatility, Pharming Group NV is 9.59 times less risky than Neutra Corp. The pink sheet trades about -0.04 of its potential returns per unit of risk. The Neutra Corp is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Neutra Corp on December 29, 2024 and sell it today you would earn a total of  0.01  from holding Neutra Corp or generate 50.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.39%
ValuesDaily Returns

Pharming Group NV  vs.  Neutra Corp

 Performance 
       Timeline  
Pharming Group NV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharming Group NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pharming Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Neutra Corp 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neutra Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Neutra Corp reported solid returns over the last few months and may actually be approaching a breakup point.

Pharming Group and Neutra Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharming Group and Neutra Corp

The main advantage of trading using opposite Pharming Group and Neutra Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharming Group position performs unexpectedly, Neutra Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neutra Corp will offset losses from the drop in Neutra Corp's long position.
The idea behind Pharming Group NV and Neutra Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing